EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

Efficacy and safety of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis (AD): a phase 2b trial (STREAM-AD)

Saturday 01 Jun, 15:24 PM - 15:36 PM Valencia, Spain